Herbas VPB

Print
EN | LT
LT - USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES
EN - USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/01
A61K 38/03
A61K 38/04
A61P 29/00
A61P 1/04
European patent
(11) Number of the document 2224941
(13) Kind of document T
(96) European patent application number 09753693.2
Date of filing the European patent application 2009-06-02
(97) Date of publication of the European application 2010-09-08
(45) Date of publication and mention of the grant of the patent 2012-02-29
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2009/003936
Date 2009-06-02
PCT application publication
(87) Number WO 2009/144038
Date 2009-12-03
Priority applications
(30) Number Date Country code
PCT/EP2008/0043 2008-05-30 WO
Inventors
(72)
BONNY, Christophe, CH
Grantee
(73) Xigen S.A., Route de la Corniche 4, 1066 Epalinges, CH
Title
(54) USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES
  USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES